#csplasma
2 stories
Haemonetics Stock Surges on CSL Plasma Deal Update
Haemonetics stock jumps 12.8% after announcing expanded supply deal with CSL Plasma.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m
Terumo Loses $610m US Customer
Terumo's US plasma device customer switches to competitors, costing $610m.
Nikkei Asia · 1m